Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)

Other Income/Expenses (Net)

-$604.00M

Quarterly · Period ending: · USD

TEVA logo

TEVA Other Income/Expenses (Net)

Latest reported-$604.00M
TEVA Quarterly Other Income/Expenses (Net) (-$22.80M → -$604.00M)
High-resolution chart · PNG

TEVA other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
-5,936,000
-6,692,000
29,922,000
-12,995,000
-46,417,000
-7,054,000
-9,478,000
-20,642,000
-3,340,000
-3,320,000
-35,200,000
-5,400,000
-1,500,000
-2,900,000
0
0
0
0
0
0
-250,200,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
192,300,000
-78,700,000
-77,800,000
-87,300,000
148,800,000
-62,600,000
-69,600,000
-65,700,000
151,600,000
-63,800,000
-68,800,000
-68,200,000
122,200,000
-46,600,000
-50,100,000
-50,000,000
-28,500,000
-26,400,000
-34,900,000
-34,900,000
-34,900,000
56,500,000
-22,800,000
-22,800,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.